Matched-unrelated-donor bone marrow transplantation for children with leukemia

Journal of the Formosan Medical Association

Volumn 104, Issue 6, 2005, Pages 448-451

  Yang, Yung Li ^a   Lu, Meng Yao ^a   Jou, Shiann Tarng ^a   Lin, Kai Hsin ^a   Lin, Dong Tsamn ^a  

^a NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

Author keywords

Bone marrow transplantation; Leukemia; Myelodysplastic syndromes; Tissue donors

Indexed keywords

ACICLOVIR; ANTIBIOTIC AGENT; BUSULFAN; CYCLOPHOSPHAMIDE; CYCLOSPORIN; ETOPOSIDE; GANCICLOVIR; IMMUNOGLOBULIN; METHOTREXATE; STEROID; TACROLIMUS;

ACUTE GRAFT VERSUS HOST DISEASE; ACUTE KIDNEY FAILURE; ADOLESCENT; ADULT; ARTICLE; BONE MARROW TRANSPLANTATION; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER RISK; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOMEGALOVIRUS; DIALYSIS; DISEASE FREE SURVIVAL; DONOR SELECTION; FEMALE; HEMORRHAGIC CYSTITIS; HUMAN; HUMAN CELL; LEUKEMIA; MALE; MYELODYSPLASIA; SEPSIS; TAIWAN; VEIN OCCLUSION; VIRUS INFECTION; WHOLE BODY RADIATION; GRAFT VERSUS HOST REACTION; HEMATOPOIETIC STEM CELL TRANSPLANTATION; MORTALITY; PRESCHOOL CHILD; RECURRENT DISEASE;

ADOLESCENT; BONE MARROW TRANSPLANTATION; CHILD; CHILD, PRESCHOOL; FEMALE; GRAFT VS HOST DISEASE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; LEUKEMIA; MALE; RECURRENCE;

EID: 23844553164     PISSN: 09296646     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (12)

1. Sanders JE: Bone marrow transplantation for pediatric malignancies. Pediatr Clin North Am 1997;44:1005-20.
2. Shaw CK, Chang TK, Chen SN, et al: HLA polymorphism and probability of finding HLA-matched unrelated marrow donors for Chinese in Taiwan. Tissue Antigens 1997;50:610-9.
3. Glucksberg H, Storb R, Fefer A, et al: Clinical manifestations of graft-versus-host disease in human recipients of marrow from HLA-matched sibling donors. Transplantation 1974;18:295-304.
4. Kernan NA, Bartsch G, Ash RC, et al: Analysis of 462 transplantations from unrelated donors facilitated by the National Marrow Donor Program. N Engl J Med 1993;328:593-602.
5. Kodera Y, Morishima Y, Kato S, et al: Analysis of 500 bone marrow transplants from unrelated donors (UR-BMT) facilitated by the Japan Marrow Donor Program: confirmation of UR-BMT as a standard therapy for patients with leukemia and aplastic anemia. Bone Marrow Transplant 1999;24:995-1003.
6. Shaw CK, Lin CL, Lin CC, et al: Marrow donor registry and bone marrow transplantation from unrelated donors in Taiwan: initial experience of the Tzu Chi Taiwan Marrow Donor Registry (TCTMDR). Bone Marrow Transplant 1999;23:727-30.
7. Woolfrey AE, Anasetti C, Storer B, et al: Factors associated with outcome after unrelated marrow transplantation for treatment of acute lymphoblastic leukemia in children. Blood 2002;99: 2002-8.
8. Knechtli CJ, Goulden NJ, Hancock JP, et al: Minimal residual disease status before allogeneic bone marrow transplantation is an important determinant of successful outcome for children and adolescents with acute lymphoblastic leukemia. Blood 1998; 92:4072-9.
9. Bader P, Hancock J, Kreyenberg H, et al: Minimal residual disease (MRD) status prior to allogeneic stem cell transplantation is a powerful predictor for post transplant outcome in children with ALL. Leukemia 2002;16:1668-72.
10. Cwynarski K, Roberts IAG, Iacobelli S, et al: Stem cell transplantation for chronic myeloid leukemia in children. Blood 2003;102:1224-31.
11. Thiesing JT, Ohno-Jones S, Kolibaba KS, et al: Efficacy of STI571, an abl tyrosine kinase inhibitor, in conjuction with other anti-leukemia agents against bcr-abl-positive cells. Blood 2000;96: 3195-9.
12. Sharathkumar A, Thornley I, Saunders EF, et al: Allogeneic bone marrow transplantation in children with chronic myelogeneous leukemia. J Pediatr Hematol Oncol 2003;24:215-9.